About Exactics
Exactics is a Chicago-based startup developing diagnostic tools for underrepresented infectious diseases. Our mission is to expedite at-home and clinical diagnoses, leading to improved treatment plans and long-term health outcomes.
We have developed QuickLyme, a patented 15-minute at-home Lyme disease test, and the Proteus+ diagnostic platform, an adaptable lateral flow immunoassay technology.
Our Story
After witnessing his best friend suffer from Lyme Disease, Julian Kage, Founder & CEO of Exactics, began researching why his friend experiences delayed diagnosis and long-term complications.
- 2017: Developed QuickLyme technology for early detection.
- 2021: Founded Exactics before continuing at the University of Chicago.
- 2023: Built a co-founding team from University of Chicago & Tulane.
Our Technology
Exactics leverages our adaptable Proteus+™ diagnostic platform, a proprietary Lateral Flow Immunoassay (LFI) technology, to rapidly develop tests that accurately detect biomarkers within 15 minutes. This flexible approach accelerates R&D at a fraction of traditional costs, enabling efficient and accessible early detection of infectious diseases—including those frequently underrepresented—and significantly enhancing disease surveillance and response capabilities.
Using our adaptable Proteus+ diagnostic platform, we enhance disease detection capabilities, making testing more efficient and widely available for underrepresented diseases.
Julian Kage
Chief Executive Officer
Dylan Murray
Chief Operating Officer
Zachary Sarmoen
Chief Financial Officer
Maxwell Almeida
Chief Technology Officer
Sean Greeby
Chief Scientific Officer
Miranda Thomson
Business Intern
John Trevino
Research Intern
Dylan Martin
Development Intern
Devin Singh
Logistics Intern
Karena Peterson
Marketing & Research Intern
Advisory Board
Our advisory board includes top medical & biotech experts from Harvard, Cambridge, and Lagos State University, with experience in infectious diseases, diagnostics, and entrepreneurship.